HydroxychloroquineCardiac toxicity following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1836卷 / 1期

关键词：

D O I：

10.1007/s40278-021-88193-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：374 / 374

相关论文

共 50 条

[1] Azithromycin/hydroxychloroquineCardiac disorder followed by off-label use: case report
[J]. Reactions Weekly, 2020, 1831 (1) : 75 - 75
[2] CrizotinibLiver toxicity following off-label use: case report
[J]. Reactions Weekly, 2015, 1551 (1) : 92 - 92
[3] VemurafenibSkin toxicity following off-label use: case report
[J]. Reactions Weekly, 2015, 1563 (1) : 212 - 212
[4] Azithromycin/hydroxychloroquineCardiac arrest following off-label use: 2 case reports
[J]. Reactions Weekly, 2020, 1830 (1) : 74 - 74
[5] DecitabineHaematological toxicity and bacterial pneumonia following off-label use: case report
[J]. Reactions Weekly, 2020, 1786 (1) : 72 - 72
[6] RuxolitinibGrade 3 liver toxicity following off-label use: case report
[J]. Reactions Weekly, 2020, 1815 (1) : 293 - 293
[7] Gilteritinib/sorafenibEnteritis following off-label use and dermal toxicity: case report
[J]. Reactions Weekly, 2023, 1973 (1) : 133 - 133
[8] RituximabPancytopenia following off-label use: case report
[J]. Reactions Weekly, 2020, 1807 (1) : 176 - 176
[9] FavipiravirNephrotoxicity following off-label use: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 283 - 283
[10] DexamethasoneHyperglycaemia following off-label use: case report
[J]. Reactions Weekly, 2022, 1896 (1) : 173 - 173

← 1 2 3 4 5 →